DE20215514U1 - Composition for oral ingestion, useful for treating renal insufficiency, comprises defined amounts of protein, carbohydrates, fats and minerals - Google Patents

Composition for oral ingestion, useful for treating renal insufficiency, comprises defined amounts of protein, carbohydrates, fats and minerals

Info

Publication number
DE20215514U1
DE20215514U1 DE20215514U DE20215514U DE20215514U1 DE 20215514 U1 DE20215514 U1 DE 20215514U1 DE 20215514 U DE20215514 U DE 20215514U DE 20215514 U DE20215514 U DE 20215514U DE 20215514 U1 DE20215514 U1 DE 20215514U1
Authority
DE
Germany
Prior art keywords
less
vitamin
protein
omega
carbohydrates
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE20215514U
Other languages
German (de)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to DE20215514U priority Critical patent/DE20215514U1/en
Publication of DE20215514U1 publication Critical patent/DE20215514U1/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A23L33/155—Vitamins A or D
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Pediatric Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

Composition for oral ingestion comprises defined amounts of protein, carbohydrates, fats and minerals. Composition for oral ingestion comprises (per daily portion): (a) protein (4-6 g); (b) carbohydrates (60-80 g), including less than 15% sugar and less than 1 g lactose; (c) fat (18-25 g), including less than 5 g saturated fatty acids (FA), 8-13 g monounsaturated FA, 5-8 g polyunsaturated FA and 1-3 g omega-3 FA, where the ratio of omega-6 FA to omega-3 FA is less than 5; and (d) sodium (less than 300 mg), potassium (less than 80 mg), calcium (more than 200 mg), magnesium (more than 40 mg) and phosphorus (less than 15 mg), where the quotient of phosphorus to protein is less than 2. ACTIVITY : Nephrotropic. No biological data given. MECHANISM OF ACTION : None given in source material.

Description

Der Beschreibungstext wurde nicht elektronisch erfaßt The description text was not recorded electronically  

Der Beschreibungstext wurde nicht elektronisch erfaßt The description text was not recorded electronically  

Der Beschreibungstext wurde nicht elektronisch erfaßt The description text was not recorded electronically  

Der Beschreibungstext wurde nicht elektronisch erfaßtThe description text was not recorded electronically

Claims (6)

1. Substanzgemisch zur oralen Einnahme, dadurch gekennzeichnet, dass in einer Tagesportion enthalten sind:
Protein 4,0-6,0 g (vorzugsweise 4,8 g)
Kohlenhydrate 60-80 g (vorzugsweise 73 g)
davon Zucker kleiner 15% (vorzugsweise < 12%)
davon Lactose kleiner 1 g (vorzugsweise < 0,1 g)
Fett 18-25 g (vorzugsweise 20 g)
davon Fettsäuren (FS)
gesättigte FS kleiner 5 g (vorzugsweise < 3 g)
einfach ungesättigte FS 8-13 g (vorzugsweise 11 g)
mehrfach ungesättigte FS 5-8 g (vorzugsweise 6,5 g) davon Omega-3-Fettsäuren 1-3 g (vorzugsweise 1,5 g)
wobei am Fettanteil
die gesättigten FS kleiner/gleich 20% sind,
die einfach ungesättigte FS größer/gleich 50% sind,
die mehrfach ungesättigte FS größer/gleich 30% sind
wobei die Ratio der Omega-6-FS zu den Omega-3-Fettsäuren kleiner 5 ist
wobei der Anteil der Omega-3-FS an den mehrfach ungesättigten FS größer 20% ist
Die Nährstoffrelation in kcal % beträgt vorzugsweise 3-5% Eiweiß, 35-40% Fett, 55-65% Kohlenhydrate. Der Mineralstoffgehalt ist für
Natrium kleiner 300 mg,
Kalium kleiner 80 mg,
Calcium größer 200 mg,
Magnesium größer 40 mg,
Phosphor kleiner 15 mg,
wobei der Quotient von Phosphor zu Eiweiß kleiner 2 ist.1. Mixture of substances for oral administration, characterized in that one daily portion contains:
Protein 4.0-6.0 g (preferably 4.8 g)
Carbohydrates 60-80 g (preferably 73 g)
of which sugar less than 15% (preferably <12%)
of which lactose less than 1 g (preferably <0.1 g)
Fat 18-25 g (preferably 20 g)
of which fatty acids (FS)
saturated FS less than 5 g (preferably <3 g)
monounsaturated FS 8-13 g (preferably 11 g)
polyunsaturated FS 5-8 g (preferably 6.5 g) thereof omega-3 fatty acids 1-3 g (preferably 1.5 g)
being the fat percentage
the saturated FS are less than or equal to 20%,
the monounsaturated FS are greater than or equal to 50%,
the polyunsaturated FS are greater than or equal to 30%
where the ratio of the Omega-6-FS to the Omega-3 fatty acids is less than 5
the proportion of omega-3 FS in the polyunsaturated FS is greater than 20%
The nutrient relation in kcal% is preferably 3-5% protein, 35-40% fat, 55-65% carbohydrates. The mineral content is for
Sodium less than 300 mg,
Potassium less than 80 mg,
Calcium greater than 200 mg,
Magnesium greater than 40 mg,
Phosphorus less than 15 mg,
where the ratio of phosphorus to protein is less than 2. 2. Substanzgemisch nach Anspruch 1, dadurch gekennzeichnet, dass zusätzlich Vitamine enthalten sind:
Vitamin A ≦ 100 µg
Vitamin D ≦ 5 µg
Vitamin E 30-50 mg
Vitamin K 30-50 µg
Vitamin B1 1,0-3,0 mg
Vitamin B2 1,0-3,0 mg
Vitamin B63,0-10,0 mg
Vitamin B12 3,0-6,0 µg
Vitamin C 60-200 mg (vorzugsweise 100 mg)
Biotin 10-100 µg
Folsäure 400-1000 µg
Nicotinamid 5-20 mg
Pantothensäure 5-20 mg2. Substance mixture according to claim 1, characterized in that vitamins are additionally contained:
Vitamin A ≦ 100 µg
Vitamin D ≦ 5 µg
Vitamin E 30-50 mg
Vitamin K 30-50 µg
Vitamin B1 1.0-3.0 mg
Vitamin B2 1.0-3.0 mg
Vitamin B63.0-10.0 mg
Vitamin B12 3.0-6.0 µg
Vitamin C 60-200 mg (preferably 100 mg)
Biotin 10-100 µg
Folic acid 400-1000 µg
Nicotinamide 5-20 mg
Pantothenic acid 5-20 mg 3. Substanzgemisch nach Anspruch 1-2, dadurch gekennzeichnet, dass zusätzlich Spuren­ elemente enthalten sind:
Selen 20-60 µg
Zink 5-20 mg
Eisen 3-5 mg
Kupfer 200-500 µg
Jod 30-80 µg
Chrom 30-80 µg
Mangan 0,2-0,6 mg
Molybdän 10-50 µg 3. Substance mixture according to claims 1-2, characterized in that trace elements are additionally contained:
Selenium 20-60 µg
Zinc 5-20 mg
Iron 3-5 mg
Copper 200-500 µg
Iodine 30-80 µg
Chromium 30-80 µg
Manganese 0.2-0.6 mg
Molybdenum 10-50 µg 4. Substanzgemisch nach Anspruch 1-3, dadurch gekennzeichnet, dass zusätzlich enthalten sind: L-Carnitin 100-1000 mg (vorzugsweise 500 mg).4. A mixture of substances according to claims 1-3, characterized marked that are also included: L-carnitine 100-1000 mg (preferably 500 mg). 5. Substanzgemisch nach Anspruch 1-4, dadurch gekennzeichnet, dass die Darreichungsform eine flüssige oder ein Pulver oder Granulat sein kann.5. A mixture of substances according to claims 1-4, characterized characterized that the dosage form can be a liquid or a powder or granules. 6. Substanzgemisch nach Anspruch 1-5, dadurch gekennzeichnet, dass es als Arzneimittel, diätetisches Lebensmittel für besondere medizinische Zwecke oder Nahrungsergänzungsmittel angeboten werden kann.6. A mixture of substances according to claims 1-5, characterized characterized it as a medicine, dietetic food for special medical Purposes or supplements offered can be.
DE20215514U 2002-10-09 2002-10-09 Composition for oral ingestion, useful for treating renal insufficiency, comprises defined amounts of protein, carbohydrates, fats and minerals Expired - Lifetime DE20215514U1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DE20215514U DE20215514U1 (en) 2002-10-09 2002-10-09 Composition for oral ingestion, useful for treating renal insufficiency, comprises defined amounts of protein, carbohydrates, fats and minerals

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE20215514U DE20215514U1 (en) 2002-10-09 2002-10-09 Composition for oral ingestion, useful for treating renal insufficiency, comprises defined amounts of protein, carbohydrates, fats and minerals

Publications (1)

Publication Number Publication Date
DE20215514U1 true DE20215514U1 (en) 2003-01-02

Family

ID=7975823

Family Applications (1)

Application Number Title Priority Date Filing Date
DE20215514U Expired - Lifetime DE20215514U1 (en) 2002-10-09 2002-10-09 Composition for oral ingestion, useful for treating renal insufficiency, comprises defined amounts of protein, carbohydrates, fats and minerals

Country Status (1)

Country Link
DE (1) DE20215514U1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008110694A2 (en) * 2007-02-02 2008-09-18 Aliscience Normo or hyperproteinated, enriched and hypercaloric food product

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008110694A2 (en) * 2007-02-02 2008-09-18 Aliscience Normo or hyperproteinated, enriched and hypercaloric food product
WO2008110694A3 (en) * 2007-02-02 2009-06-11 Aliscience Normo or hyperproteinated, enriched and hypercaloric food product

Similar Documents

Publication Publication Date Title
Blake et al. Effect of calcium and phosphorus on the gastrointestinal absorption of 203Pb in man
DE69935995T2 (en) POLYUNGATURATED FATTY ACIDS NUTRITIONAL SUPPLEMENT
EP1876906B1 (en) Nutritional supplement or functional food comprising oil combination
CN1328966C (en) Nutritional composition for dietary supplements
AU2001256142A1 (en) A nutritional composition for dietary supplements
WO2008138821A1 (en) Milk fat-milk protein composition (preferably esterified with palmitic acid) for improving calcium absorption
DE20215514U1 (en) Composition for oral ingestion, useful for treating renal insufficiency, comprises defined amounts of protein, carbohydrates, fats and minerals
AU757377B2 (en) Method for increasing the concentration of conjugated linoleic acid in milk and/or tissue fat of a ruminant
DE20205184U1 (en) Blood lipid lowerers for oral use
JP2008237058A (en) Dietary supplement
US6228367B1 (en) Food supplement formulation
DE10214005A1 (en) Orally administered dietetic, nutritional supplement or medicament composition, useful as hypolipemic agent, comprising mixture of pectin and/or guar powder with eicosapentaenoic and docosahexaenoic acids
Tichelaar et al. The effect of dietary iron deficiency on the fatty acid composition of plasma and erythrocyte membrane phospholipids in the rat
US20050222259A1 (en) Methods of activating PPAR-alpha nuclear receptors in mammals
JPH0823941A (en) Healthy beverage
Gillingham The metabolic fate of alpha linolenic acid (ALA)
US4591506A (en) Oral ingestion of indium
JPS62224258A (en) Nourishing food
EP1214894B1 (en) Food formulations with a high calcium content
Minnis et al. Oily fish and fish oil supplements in the prevention of coronary heart disease
RU2125818C1 (en) Concentrate of vitamin-and-mineral beverage &#34;zolotoi shar&#34; (versions)
Inobeme et al. Benefits of Geochemistry and Its Impact on Human Health
US7172773B2 (en) Food supplement formulation
NL2018302B1 (en) Composition for use in the treatment and / or prevention of a deficiency of vitamins, minerals and / or trace elements.
Patiukova Practical aspects of adding polyunsaturated fatty acids (PUFA) in daily diet

Legal Events

Date Code Title Description
R207 Utility model specification

Effective date: 20030206

R163 Identified publications notified

Effective date: 20030813

R156 Lapse of ip right after 3 years

Effective date: 20060503